(Total Views: 219)
Posted On: 11/24/2019 7:08:50 AM
Post# of 36566
Here is the PR statement:
Joseph Moscato, Generex President & Chief Executive Officer stated: “I look forward to this conference call and invite all of our valuable shareholders to attend.” This call will cover the newly paid 1:1 dividend, our new spin out to the public of NuGenerex Immuno-oncology and the new proposed dividend to Generex shareholders of this company and the closing of the Altucell acquisition closing, as well as other corporate initiatives that are ongoing such as our Nasdaq listing which is still in process.
_______________________________________________________
OK. Thanks. I would have added "rights offering" in the statement. The last thing GNBT PPS needs is the perception/confusion there could be even more Generex shares added to the float. I see that it should be NGIO.
I really hope there will be demand from private accredited individual investors and other groups for such an offering.
Joseph Moscato, Generex President & Chief Executive Officer stated: “I look forward to this conference call and invite all of our valuable shareholders to attend.” This call will cover the newly paid 1:1 dividend, our new spin out to the public of NuGenerex Immuno-oncology and the new proposed dividend to Generex shareholders of this company and the closing of the Altucell acquisition closing, as well as other corporate initiatives that are ongoing such as our Nasdaq listing which is still in process.
_______________________________________________________
OK. Thanks. I would have added "rights offering" in the statement. The last thing GNBT PPS needs is the perception/confusion there could be even more Generex shares added to the float. I see that it should be NGIO.
I really hope there will be demand from private accredited individual investors and other groups for such an offering.
(0)
(0)
